Sign up to save your podcasts
Or
Share Lead: Prescriber-Level Changes in Buprenorphine Dispensing in the USA Before and After Federal Policy Changes Aimed at Increasing Prescribing
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Lead: Prescriber-Level Changes in Buprenorphine Dispensing in the USA Before and After Federal Policy Changes Aimed at Increasing Prescribing
Prescriber-Level Changes in Buprenorphine Dispensing in the USA Before and After Federal Policy Changes Aimed at Increasing Prescribing
Journal of General Internal Medicine
This study used interrupted-time-series analysis to model prescriber-level trends in buprenorphine prescriptions after recent federal policy changes. It found that the elimination of the waiver requirement to prescribe buprenorphine in December 2022 was associated with a significant increase in the number of buprenorphine prescribers, but a decrease in the mean number of patients and the mean number of prescriptions per prescriber. Changes in telehealth flexibilities and relaxed training requirements were largely not associated with prescribing changes. This study expands on prior research by providing further insight as to why waiver elimination has not increased the number of patients receiving buprenorphine, as expected.
Read this issue of the ASAM Weekly
Subscribe to the ASAM Weekly
Visit ASAM
View all episodes
By American Society of Addiction Medicine
4.9
77 ratings
Prescriber-Level Changes in Buprenorphine Dispensing in the USA Before and After Federal Policy Changes Aimed at Increasing Prescribing
Journal of General Internal Medicine
This study used interrupted-time-series analysis to model prescriber-level trends in buprenorphine prescriptions after recent federal policy changes. It found that the elimination of the waiver requirement to prescribe buprenorphine in December 2022 was associated with a significant increase in the number of buprenorphine prescribers, but a decrease in the mean number of patients and the mean number of prescriptions per prescriber. Changes in telehealth flexibilities and relaxed training requirements were largely not associated with prescribing changes. This study expands on prior research by providing further insight as to why waiver elimination has not increased the number of patients receiving buprenorphine, as expected.
Read this issue of the ASAM Weekly
Subscribe to the ASAM Weekly
Visit ASAM
More shows like This Week in Addiction Medicine from ASAM
View all
NEI Podcast
129 Listeners
AFP: American Family Physician Podcast
706 Listeners
Mayo Clinic Talks
281 Listeners
Frankly Speaking About Family Medicine
253 Listeners
The Curbsiders Internal Medicine Podcast
3,336 Listeners
Addiction Medicine: Beyond the Abstract
31 Listeners
Psychiatry & Psychotherapy Podcast
1,321 Listeners
Real Life Pharmacology - Pharmacology Education for Health Care Professionals
716 Listeners
Psychopharmacology and Psychiatry Updates
290 Listeners
The Carlat Psychiatry Podcast
562 Listeners
The Curbsiders Addiction Medicine Podcast
122 Listeners
Addiction Medicine Journal Club
33 Listeners
Psychiatry Boot Camp
175 Listeners
PsychRounds: The Psychiatry Podcast
112 Listeners
ASAM Practice Pearls
17 Listeners